New study to track IBD patients on guselkumab in saudi arabia
NCT ID NCT07541261
First seen Apr 24, 2026 · Last updated May 12, 2026 · Updated 3 times
Summary
This study will follow about 100 adults in Saudi Arabia who have moderate to severe Crohn's disease or ulcerative colitis and are starting the drug guselkumab. Researchers want to see how long patients continue their treatment in everyday medical practice. The study does not give any new treatment or change care—it simply observes what happens in real-world clinics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.